Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Phase III study evaluates efficacy of tacrolimus in bone marrow transplantation

Oct. 29, 1998

Aquila's malaria vaccine immunogenic and well tolerated in phase I trial

Oct. 28, 1998

Vasogen files for protection of patient-specific treatment of GvHD

Oct. 27, 1998

Simulect gets the go-ahead from the European Commission

Oct. 23, 1998

Astra patents novel immunosuppressive agents

Oct. 22, 1998

Oxo Chemie initiates phase III trial of compound for late-stage HIV infection

Oct. 21, 1998

Ribi, ATL collaborate on the development of improved allergy vaccines

Oct. 20, 1998

Certiva vaccine launched in the U.S.

Oct. 16, 1998

Orphan drug designation granted to MEDI-507 for use in AlloMune system

Oct. 16, 1998

Data safety monitoring board deems Nabi S. aureus vaccine safe in hemodialysis patients

Oct. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...